Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement
Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement
复制标题
DOI：
--
复制
发表时间：
2010-12
期刊：
影响因子：
--
通讯作者：
Clsi
中科院分区：
文献类型：
--
作者：
Clsi
本文件中提供的补充信息预期与以下临床和实验室标准协会（CLSI）批准的标准中发布的抗菌药物敏感性试验程序一起使用：M02-A10-抗菌药物纸片敏感性试验的性能标准;批准的标准-第十版;和M07-A8-需氧生长细菌的稀释抗菌药物敏感性试验方法;批准的标准-第八版。标准品包含有关需氧菌的纸片（M02）和稀释（M07）检测程序的信息。临床医生在很大程度上依赖于临床微生物学实验室的信息来治疗他们的重病患者。抗菌药物敏感性试验结果的临床重要性要求这些试验在最佳条件下进行，并且实验室有能力提供最新抗菌药物的结果。此处列出的表格信息代表了使用M02和M07中标准化程序进行药物选择、解释和质量控制的最新信息。用户应该用这些新表替换以前发布的表。（自最新版本以来各表中的变动以黑体字显示。
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A10— Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Tenth Edition ; and M07-A8— Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Eighth Edition . The standards contain information about both disk (M02) and dilution (M07) test procedures for aerobic bacteria. Clinicians depend heavily on information from the clinical microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results requires that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and quality control using the procedures standardized in M02 and M07. Users should replace the tables published earlier with these new tables. (Changes in the tables since the most current edition appear in boldface type.)